HIGHLIGHTS
- who: Momordica charantia L.- and colleagues from the Department of Pharmaceutical Biology, Institute of Pharmacy, Kiel University, Kiel, Germany have published the article: Momordica charantia L. u2014 Diabetes-Related Bioactivities, Quality Control, and Safety Considerations, in the Journal: (JOURNAL) of 17/05/2022
- how: All of the isolates were tested for their inhibition of u03b1-glucosidase however with no effect compared to acarbose.
- future: Future studies should apply formulations (preferably made of extracts) with a defined amount of daily intake.
SUMMARY
This shortcoming and the high bias associated with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.